Diabetes, Vol 43, Issue 11 1378-1389, Copyright © 1994 by American Diabetes Association

ARTICLES

Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM

PE Cryer
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Iatrogenic hypoglycemia is the limiting factor in the management of insulin-dependent diabetes mellitus (IDDM). It causes recurrent physical morbidity, some mortality, and recurrent or even persistent psychosocial morbidity. The principles of glucose counterregulation, the physiological mechanisms that normally very effectively prevent or correct hypoglycemia, are now known. Decrements in insulin, increments in glucagon, and, in the absence of the latter, increments in epinephrine stand high in the hierarchy of redundant glucose counterregulatory factors. Iatrogenic hypoglycemia in IDDM is the result of the interplay of absolute or relative therapeutic insulin excess and compromised glucose counterregulation. Syndromes of compromised glucose counterregulation include defective glucose counterregulation (the result of combined deficiencies of the glucagon and epinephrine responses to falling glucose levels), hypoglycemia unawareness (loss of the warning, neurogenic symptoms of developing hypoglycemia), and elevated glycemic thresholds (lower glucose levels required) for autonomic activation and symptoms during effective intensive therapy. These have been conceptualized as examples of hypoglycemia-associated autonomic failure, a functional disorder distinct from classical diabetic autonomic neuropathy, in IDDM. Recent antecedent iatrogenic hypoglycemia appears to be a major factor in the pathogenesis of hypoglycemia unawareness; there is increasing evidence that this syndrome is reversible with scrupulous avoidance of hypoglycemia. It probably also contributes substantially to the syndrome of elevated glycemic thresholds during intensive therapy. However, factors in addition to recent antecedent hypoglycemia play an important role in the pathogenesis of the syndrome of defective glucose counterregulation. Pending the prevention and cure of IDDM, we need to learn to replace insulin in a much more physiological fashion and/or to prevent, correct, or compensate for compromised glucose counterregulation if we are to eliminate hypoglycemia from the lives of people with IDDM without compromising glycemic control. In the meantime, we must continue to seek better insight into the fundamental mechanisms of compromised glucose counterregulation and to develop practical preventive clinical strategies and practice hypoglycemia risk factor reduction with our patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. J. Briscoe, A. C. Ertl, D. B. Tate, and S. N. Davis Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Counterregulatory Responses to Hypoglycemia in Individuals With Type 1 Diabetes Diabetes, December 1, 2008; 57(12): 3315 - 3322. [Abstract] [Full Text] [PDF]

				P. Rossetti, F. Porcellati, N. Busciantella Ricci, P. Candeloro, P. Cioli, K. S. Nair, F. Santeusanio, G. B. Bolli, and C. G. Fanelli Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People Diabetes, July 1, 2008; 57(7): 1905 - 1917. [Abstract] [Full Text] [PDF]

				A. D. Cherrington Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia Diabetes, May 1, 2008; 57(5): 1158 - 1159. [Full Text] [PDF]

				P. Rossetti, F. Porcellati, N. B. Ricci, P. Candeloro, P. Cioli, G. B. Bolli, and C. G. Fanelli Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans Diabetes, March 1, 2008; 57(3): 746 - 756. [Abstract] [Full Text] [PDF]

				R. J. McCrimmon, M. Shaw, X. Fan, H. Cheng, Y. Ding, M. C. Vella, L. Zhou, E. C. McNay, and R. S. Sherwin Key Role for AMP-Activated Protein Kinase in the Ventromedial Hypothalamus in Regulating Counterregulatory Hormone Responses to Acute Hypoglycemia Diabetes, February 1, 2008; 57(2): 444 - 450. [Abstract] [Full Text] [PDF]

				H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E705 - E712. [Abstract] [Full Text] [PDF]

				A. V. Matveyenko, M. Bohland, M. Saberi, and C. M. Donovan Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E857 - E864. [Abstract] [Full Text] [PDF]

				D. J. Cox, L. Gonder-Frederick, L. Ritterband, W. Clarke, and B. P. Kovatchev Prediction of Severe Hypoglycemia Diabetes Care, June 1, 2007; 30(6): 1370 - 1373. [Abstract] [Full Text] [PDF]

				D. G. Marrero, J. Crean, B. Zhang, T. Kellmeyer, M. Gloster, K. Herrmann, R. Rubin, N. Fineberg, and O. Kolterman Effect of Adjunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type 1 Diabetes Diabetes Care, February 1, 2007; 30(2): 210 - 216. [Abstract] [Full Text] [PDF]

				A. S. Gangji, T. Cukierman, H. C. Gerstein, C. H. Goldsmith, and C. M. Clase A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin Diabetes Care, February 1, 2007; 30(2): 389 - 394. [Abstract] [Full Text] [PDF]

				N. C. Tkacs and H. J. Thompson From bedside to bench and back again: research issues in animal models of human disease. Biol Res Nurs, July 1, 2006; 8(1): 78 - 88. [Abstract] [PDF]

				G. F. Mason, K. F. Petersen, V. Lebon, D. L. Rothman, and G. I. Shulman Increased brain monocarboxylic Acid transport and utilization in type 1 diabetes. Diabetes, April 1, 2006; 55(4): 929 - 934. [Abstract] [Full Text] [PDF]

				O. Chan, W. Zhu, Y. Ding, R. J. McCrimmon, and R. S. Sherwin Blockade of GABAA Receptors in the Ventromedial Hypothalamus Further Stimulates Glucagon and Sympathoadrenal but Not the Hypothalamo-Pituitary-Adrenal Response to Hypoglycemia. Diabetes, April 1, 2006; 55(4): 1080 - 1087. [Abstract] [Full Text] [PDF]

				D. F. Kruger, C. L. Martin, and C. E. Sadler New insights into glucose regulation. The Diabetes Educator, March 1, 2006; 32(2): 221 - 228. [Abstract] [Full Text] [PDF]

				A Brackenridge, H Wallbank, R A Lawrenson, and D Russell-Jones Emergency management of diabetes and hypoglycaemia Emerg. Med. J., March 1, 2006; 23(3): 183 - 185. [Abstract] [Full Text] [PDF]

				P. Kishore, I. Gabriely, M.-H. Cui, J. Di Vito, S. Gajavelli, J.-H. Hwang, and H. Shamoon Role of Hepatic Glycogen Breakdown in Defective Counterregulation of Hypoglycemia in Intensively Treated Type 1 Diabetes Diabetes, March 1, 2006; 55(3): 659 - 666. [Abstract] [Full Text] [PDF]

				R. J. McCrimmon, M. L. Evans, X. Fan, E. C. McNay, O. Chan, Y. Ding, W. Zhu, D. X. Gram, and R. S. Sherwin Activation of ATP-Sensitive K+ Channels in the Ventromedial Hypothalamus Amplifies Counterregulatory Hormone Responses to Hypoglycemia in Normal and Recurrently Hypoglycemic Rats Diabetes, November 1, 2005; 54(11): 3169 - 3174. [Abstract] [Full Text] [PDF]

				N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF]

				American Diabetes Association Diabetes Care at Diabetes Camps Diabetes Care, January 1, 2005; 28(suppl_1): S50 - S52. [Full Text] [PDF]

				Diabetes Care at Diabetes Camps Diabetes Care, January 1, 2004; 27(90001): s129 - 131. [Full Text] [PDF]

				B. E. de Galan, S. J. Rietjens, C. J. Tack, S. P. van der Werf, C. G. J. Sweep, J. W. M. Lenders, and P. Smits Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5462 - 5467. [Abstract] [Full Text] [PDF]

				S. Enoksson, S. K. Caprio, F. Rife, G. I. Shulman, W. V. Tamborlane, and R. S. Sherwin Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1503 - 1511. [Abstract] [Full Text] [PDF]

				M. W. Steffes, S. Sibley, M. Jackson, and W. Thomas {beta}-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial Diabetes Care, March 1, 2003; 26(3): 832 - 836. [Abstract] [Full Text] [PDF]

				D. E. Flanagan, T. Keshavarz, M. L. Evans, S. Flanagan, X. Fan, R. J. Jacob, and R. S. Sherwin Role of Corticotrophin-Releasing Hormone in the Impairment of Counterregulatory Responses to Hypoglycemia Diabetes, March 1, 2003; 52(3): 605 - 613. [Abstract] [Full Text] [PDF]

				Management of Diabetes at Diabetes Camps Diabetes Care, January 1, 2003; 26(90001): s136 - 138. [Full Text] [PDF]

				N. Younis, H. Soran, and D. Bowen-Jones Insulin glargine: a new basal insulin analogue QJM, November 1, 2002; 95(11): 757 - 761. [Full Text] [PDF]

				V. P. McGregor, J. S. Greiwe, S. Banarer, and P. E. Cryer Limited Impact of Vigorous Exercise on Defenses Against Hypoglycemia: Relevance to Hypoglycemia-Associated Autonomic Failure Diabetes, May 1, 2002; 51(5): 1485 - 1492. [Abstract] [Full Text] [PDF]

				S. Banarer, V. P. McGregor, and P. E. Cryer Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response Diabetes, April 1, 2002; 51(4): 958 - 965. [Abstract] [Full Text] [PDF]

				B. E. de Galan, C. J. Tack, J. W. Lenders, J. W. Pasman, L. D. Elving, F. G. Russel, J. A. Lutterman, and P. Smits Theophylline Improves Hypoglycemia Unawareness in Type 1 Diabetes Diabetes, March 1, 2002; 51(3): 790 - 796. [Abstract] [Full Text] [PDF]

				C. Schofl, A. Schleth, D. Berger, C. Terkamp, A. von zur Muhlen, and G. Brabant Sympathoadrenal Counterregulation in Patients with Hypothalamic Craniopharyngioma J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 624 - 629. [Abstract] [Full Text] [PDF]

				P. E. Cryer and B. P. Childs Negotiating the Barrier of Hypoglycemia in Diabetes Diabetes Spectr, January 1, 2002; 15(1): 20 - 27. [Abstract] [Full Text] [PDF]

				K. Shum, K. Inouye, O. Chan, J. Mathoo, D. Bilinski, S. G. Matthews, and M. Vranic Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E455 - E465. [Abstract] [Full Text] [PDF]

				E. Cersosimo, P. Garlick, and J. Ferretti Abnormal Glucose Handling by the Kidney in Response to Hypoglycemia in Type 1 Diabetes Diabetes, September 1, 2001; 50(9): 2087 - 2093. [Abstract] [Full Text] [PDF]

				S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia Diabetes, August 1, 2001; 50(8): 1911 - 1917. [Abstract] [Full Text] [PDF]

				W. I. Sivitz, J. A. Herlein, D. A. Morgan, B. D. Fink, B. G. Phillips, and W. G. Haynes Effect of Acute and Antecedent Hypoglycemia on Sympathetic Neural Activity and Catecholamine Responsiveness in Normal Rats Diabetes, May 1, 2001; 50(5): 1119 - 1125. [Abstract] [Full Text]

				R. Guthrie Is There a Need for a Better Basal Insulin? Clin. Diabetes, April 1, 2001; 19(2): 66 - 70. [Abstract] [Full Text] [PDF]

				A. Fritsche, M. Stumvoll, H. U. Häring, and J. E. Gerich Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of {beta}-Adrenergic Sensitivity after Prevention of Hypoglycemia J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 523 - 525. [Abstract] [Full Text]

				B. Fruehwald-Schultes, W. Kern, E. Deininger, P. Wellhoener, W. Kerner, J. Born, H. L. Fehm, and A. Peters Protective Effect of Insulin against Hypoglycemia-Associated Counterregulatory Failure J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1551 - 1557. [Abstract] [Full Text]

				E. Dumonteil, C. Magnan, B. Ritz-Laser, P. Meda, P. Dussoix, M. Gilbert, A. Ktorza, and J. Philippe Insulin, But Not Glucose Lowering Corrects the Hyperglucagonemia and Increased Proglucagon Messenger Ribonucleic Acid Levels Observed in Insulinopenic Diabetes Endocrinology, November 1, 1998; 139(11): 4540 - 4546. [Abstract] [Full Text] [PDF]